E

Overcoming challenges associated with cell therapy approaches

Insights from Transplantation & Cellular Therapy (TCT) meeting on the next generation of CAR T cells

February 21, 2020
E

Whipping up a frenzy in CAR-T cell future developments

In this post we look at an emerging research area that will be important to address if CAR T cell therapy is to be effective in solid tumours

February 13, 2020
E

Quest for the Holy Grail of Cell Therapy

CAR T cell therapy for solid tumors is the cancer new product development equivalent of the quest for the "Holy Grail."

February 11, 2020
E

What does the next decade hold for CAR T cell therapy?

Interview with Dr Carl June on what the next decade holds for CAR T cells, cell therapy and genome engineering

February 6, 2020
E

A delicate question of balance

Interview with Prof John Gribben at second European EHA EBMT CAR T cell therapy meeting in Sitges, Spain

February 5, 2020
E
Sitges Sunrise

Chasing the Light in Cell Therapy

Commentary on Day 2 of the EHA EBMT 2nd European CAR T cell meeting

February 1, 2020
E

Shooting for the stars with next generation cell therapies

Commentary on first day of EHA EBMT European CAR T meeting in Sitges, Spain

January 31, 2020
E
Aerial View Thames Estuary

Emerging Gamma Delta T Cell Cancer Immunotherapy Landscape

A look at the γδ T cell competitive landscape with cell therapies, antibodies and bispecifics in early stage development

February 27, 2019
E

Exploring Gamida Cell with Dr Julian Adams

A look at what Gamida Cell, an up and coming cellular and innate immunotherapy company are up to...

March 15, 2018
E

Are fast or slow CARs better for the future?

In this post, we take a look at new clinical and scientific findings that may pave the way forward for the future in the CAR T cell space

February 26, 2018
E

Future of CAR T Cell Therapy for Leukemia and Lymphoma

What did Dr Grupp and Dr Komanduri learn from participation in the CAR T cell therapy trials?

February 22, 2018
E

BMT Tandem Cell Therapy Insights

Insight from BMT Tandem 2017 meeting into latest Cell Therapy data

February 27, 2017
E

Making CAR T cell therapy more effective in leukemia and solid tumors

Finding new ways to optimise CAR T cell therapy in CLL and solid tumours may be closer than you think...

March 15, 2016
E

Trends in Haplo transplants impact Bellicum

Trends in Haplo stem cell transplants may impact Bellicum Pharmaceuticals adjunct T Cell therapy BPX–501

March 9, 2016
E

Is TIM–3 the next important checkpoint target?

Could immune resistance be reversed or prevented by the addition of appropriate checkpoint blockade? Which ones matter though, that is the critical question?

March 3, 2016
E

Could a Novel Cell Therapy replace CAR T Cell Therapy?

Interview at BMT Tandem 2016 about a novel cell therapy that could compete with or replace CAR T cell therapy

March 1, 2016
E

Are checkpoints playing with fire?

Commentary on presentation by Dr Philippe Armand at BMT Tandem meeting on “Checkpoint Blockade in SCT, Data & Hope, Promise & Peril”

February 25, 2016
E

Optimizing CD19 CAR T Cell Therapy

Interview with Dr Michael Jensen on CD19 CAR T Cell Therapy

February 23, 2016
E

Challenges and Opportunities of CAR T Cell Therapy in CLL

Interview at BMT Tandem 2016 with Dr David Porter U Penn on CD19 targeted CAR T cell therapy in CLL

February 19, 2016
E

What’s hot at BMT Tandem 2016 in Honolulu?

Preview of noteworthy sessions at 2016 BMT Tandem meeting in Honolulu, Hawaii

February 17, 2016
E

What’s driving the GvHD Landscape? #BMTTandem16

What are some of the strategic trends and drivers in the Graft versus Host Disease (GvHD) space at #BMTTandem16?

February 9, 2016
E

Immunotherapy for Lymphoma using T cells Targeting Multiple Tumor-Associated Antigens

A novel cell therapy approach uses T cells targeting multiple tumor-associated antigens.

February 3, 2016
E

CAR-T and Gene Therapy excite BMT Tandem Meeting

Dr Krishna Komanduri discusses some of the best abstracts at the 2015 BMT Tandem meeting in San Diego.

February 25, 2015
E

UCL Drives CD19 CAR T Cell Therapy Forward in Europe

University College London (UCL) is leading the way in European clinical trials of CAR T Cell therapies that target CD19.

April 14, 2015
E

Anti-CTLA4 blockade with ipilimumab may be effective in hematologic malignancies

Does checkpoint blockade with CTLA4 have a role to play in hematologic malignancies?

April 15, 2015